M. Desideri

发表

Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations.

R. Foà, S. Chiaretti, G. Zupi, 2009, Neoplasia.

Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.

D. Trisciuoglio, G. Zupi, M. Milella, 2006, Cancer research.

Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells

D. Trisciuoglio, E. Ziparo, M. Desideri, 2011, Cell Death and Differentiation.

Bcl-2 Regulates HIF-1α Protein Stabilization in Hypoxic Melanoma Cells via the Molecular Chaperone HSP90

D. Trisciuoglio, G. Zupi, E. Ziparo, 2010, PloS one.

Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages

V. Farini, A. Sica, E. Gallo, 2020, Journal for ImmunoTherapy of Cancer.

455 Bcl-2 regulates HIF-1alpha protein stabilization in hypoxic melanoma cells via the molecular chaperone HSP90

D. Trisciuoglio, G. Zupi, E. Ziparo, 2010 .

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells

S. Carradori, D. Trisciuoglio, A. Mai, 2016, Oncotarget.

Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.

D. Trisciuoglio, G. Zupi, A. Orlandi, 2009, European journal of cancer.

Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb

D. Trisciuoglio, B. Calabretta, M. Rizzo, 2018, Journal of Experimental & Clinical Cancer Research.

BH4 domain of bcl-2 protein is required for its proangiogenic function under hypoxic condition.

M. Biffoni, D. Trisciuoglio, M. Rizzo, 2013, Carcinogenesis.

Modulation of bcl-xL in Tumor Cells Regulates Angiogenesis through CXCL8 Expression

D. Trisciuoglio, G. Zupi, U. Zangemeister‐Wittke, 2007, Molecular Cancer Research.

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells

V. Farini, S. Carradori, D. Trisciuoglio, 2020, Journal of experimental & clinical cancer research : CR.

LMNA Knock-Down Affects Differentiation and Progression of Human Neuroblastoma Cells

I. Arisi, R. Brandi, D. Trisciuoglio, 2012, PloS one.

NAADP-Dependent Ca2+ Signaling Controls Melanoma Progression, Metastatic Dissemination and Neoangiogenesis

A. Filippini, E. Ziparo, F. Padula, 2016, Scientific Reports.

VEGF-induced neoangiogenesis is mediated by NAADP and two-pore channel-2–dependent Ca2+ signaling

A. Galione, A. Filippini, E. Ziparo, 2014, Proceedings of the National Academy of Sciences.

Caspase-8 contributes to angiogenesis and chemotherapy resistance in glioblastoma

D. Centonze, F. Ferrè, D. Trisciuoglio, 2017, eLife.

Down-regulation of the PTTG1 proto-oncogene contributes to the melanoma suppressive effects of the cyclin-dependent kinase inhibitor PHA-848125.

E. Bonmassar, L. Levati, D. Del Bufalo, 2012, Biochemical pharmacology.

CPTH6, a Thiazole Derivative, Induces Histone Hypoacetylation and Apoptosis in Human Leukemia Cells

L. Ricci-Vitiani, S. Carradori, D. Trisciuoglio, 2011, Clinical Cancer Research.

Bcl‐2 overexpression in melanoma cells increases tumor progression‐associated properties and in vivo tumor growth

D. Ribatti, D. Trisciuoglio, G. Zupi, 2005, Journal of cellular physiology.

microRNA-378a-5p iS a novel positive regulator of melanoma progression

L. Fattore, R. Mancini, G. Ciliberto, 2020, Oncogenesis.

BCL-XL overexpression promotes tumor progression-associated properties

D. Trisciuoglio, D. Del Bufalo, M. Desideri, 2017, Cell Death & Disease.

TLR3 engagement induces IRF-3-dependent apoptosis in androgen-sensitive prostate cancer cells and inhibits tumour growth in vivo

A. Filippini, E. Ziparo, F. Padula, 2014, Journal of cellular and molecular medicine.

Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.

D. Del Bufalo, M. Desideri, A. Stoppacciaro, 2013, Thyroid : official journal of the American Thyroid Association.

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma

Nicola Baldini, Michele Milella, D. Trisciuoglio, 2018, Oncogenesis.

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

D. Trisciuoglio, M. Milella, D. Del Bufalo, 2014, Molecular Cancer.

miR‐211 and MITF modulation by Bcl‐2 protein in melanoma cells

V. Farini, D. Trisciuoglio, M. Rizzo, 2016, Molecular carcinogenesis.

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms

R. Maria, J. McCubrey, G. Blandino, 2012, Journal of Molecular Medicine.

Removal of the BH4 domain from Bcl-2 protein triggers an autophagic process that impairs tumor growth.

D. Trisciuoglio, A. Orlandi, D. Del Bufalo, 2013, Neoplasia.

Affinity purification-mass spectrometry analysis of bcl-2 interactome identified SLIRP as a novel interacting protein

V. Farini, D. Trisciuoglio, A. Urbani, 2016, Cell Death and Disease.

Histone deacetylase inhibition synergistically enhances pemetrexed cytotoxicity through induction of apoptosis and autophagy in non-small cell lung cancer

D. Trisciuoglio, M. Milella, D. Del Bufalo, 2014, Molecular Cancer.

BCL-XL overexpression promotes tumor progression-associated properties

D. Trisciuoglio, D. Del Bufalo, M. Desideri, 2017, Cell Death & Disease.

The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms

R. Maria, J. McCubrey, G. Blandino, 2012, Journal of molecular medicine.

The thiazole derivative CPTH6 impairs autophagy

S. Carradori, D. Trisciuoglio, D. Del Bufalo, 2013, Cell Death and Disease.